Mahmut Mert Erçel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mahmut Mert Erçel has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Aslınur Özkaya Parlakay
Clinic of Pediatric Infectious Diseases, Ankara Bilkent City Hospital, Ankara Yıldırım Beyazıt University, Ankara, Türkiye
2 shared publications - Büşra Demirci
Department of Pediatrics, Ankara Bilkent City Hospital, Ankara, Türkiye
2 shared publications - Gonca Türker Ergün
Ankara Bilkent Şehir Hastanesi
2 shared publications - Sevinc Puren Yucel
Department of Biostatistics, Cukurova University, Adana, Türkiye
2 shared publications - Betül Siyah Bilgin
Department of Neonatology University of Health Sciences, Ankara Bilkent City Hospital Ankara Çankaya Turkey
1 shared publication - Burak Özdemir
Department of Pediatrics, Ankara Bilkent City Hospital, 06800 Ankara, Turkey
1 shared publication
Latest Publications
- 12 October 2026
- Published by Bilimsel Tip Publishing House in Journal of Pediatric Infection
- Vol. 20 (3) , e217-e225
Maternal Awareness, Attitudes, and Acceptance Toward the RSVpreF Vaccine: A Cross-Sectional Study Among Pregnant in Türkiye
- 12 October 2026
- Published by Bilimsel Tip Publishing House in Journal of Pediatric Infection
- Vol. 20 (3) , e217-e225
Maternal Awareness, Attitudes, and Acceptance Toward the RSVpreF Vaccine: A Cross-Sectional Study Among Pregnant in Türkiye
- 12 October 2026
- Published by Bilimsel Tip Publishing House in Journal of Pediatric Infection
- Vol. 20 (3) , 210-218
Türkiye’de Gebe Kadınlarda RSVpreF Aşısına Yönelik Farkındalık, Tutum ve Kabul Düzeyleri: Kesitsel Bir Çalışma
- 12 October 2026
- Published by Bilimsel Tip Publishing House in Journal of Pediatric Infection
- Vol. 20 (3) , 210-218
Türkiye’de Gebe Kadınlarda RSVpreF Aşısına Yönelik Farkındalık, Tutum ve Kabul Düzeyleri: Kesitsel Bir Çalışma
- Open Access
Red Cell Distribution Width and RDW-to-Platelet Ratio Patterns Across the Spectrum of Hypoxic–Ischemic Encephalopathy
Background: Red cell distribution width (RDW) and the RDW-to-platelet ratio (RPR) have emerged as readily available hematologic markers reflecting systemic inflammation in neonates with hypoxic–ischemic encephalopathy (HIE); however, their early postnatal trajectories across the clinical spectrum of HIE remain insufficiently characterized. Methods: This retrospective cohort study included 229 term or near-term infants diagnosed with HIE. Among them, 166 infants received therapeutic hypothermia, whereas 63 infants who did not undergo cooling served as the reference group. RDW and RPR values were measured at birth and at 72 h of life (after completion of cooling in the hypothermia group). Results: In the reference group, RDW values significantly decreased at 72 h, reflecting normal postnatal hematologic adaptation. In contrast, the hypothermia group demonstrated a blunted decline, with RDW levels remaining relatively stable over the first 72 h, consistent with a blunted early postnatal RDW decline. RPR values showed a mild, non-significant upward trend during the first 72 h of life; however, exploratory analyses suggested an association between higher RPR levels and increasing HIE severity. Conclusions: Across the spectrum of hypoxic–ischemic encephalopathy, RDW demonstrated a blunted postnatal decline, whereas RPR showed a mild, non-significant increase during the early neonatal period. These readily available hematologic markers may provide complementary insights into early systemic inflammatory and hematologic responses in HIE. Prospective multicenter studies are needed to determine their prognostic value and relationship with clinical and neurodevelopmental outcomes.
Open AccessRed Cell Distribution Width and RDW-to-Platelet Ratio Patterns Across the Spectrum of Hypoxic–Ischemic Encephalopathy
Background: Red cell distribution width (RDW) and the RDW-to-platelet ratio (RPR) have emerged as readily available hematologic markers reflecting systemic inflammation in neonates with hypoxic–ischemic encephalopathy (HIE); however, their early postnatal trajectories across the clinical spectrum of HIE remain insufficiently characterized. Methods: This retrospective cohort study included 229 term or near-term infants diagnosed with HIE. Among them, 166 infants received therapeutic hypothermia, whereas 63 infants who did not undergo cooling served as the reference group. RDW and RPR values were measured at birth and at 72 h of life (after completion of cooling in the hypothermia group). Results: In the reference group, RDW values significantly decreased at 72 h, reflecting normal postnatal hematologic adaptation. In contrast, the hypothermia group demonstrated a blunted decline, with RDW levels remaining relatively stable over the first 72 h, consistent with a blunted early postnatal RDW decline. RPR values showed a mild, non-significant upward trend during the first 72 h of life; however, exploratory analyses suggested an association between higher RPR levels and increasing HIE severity. Conclusions: Across the spectrum of hypoxic–ischemic encephalopathy, RDW demonstrated a blunted postnatal decline, whereas RPR showed a mild, non-significant increase during the early neonatal period. These readily available hematologic markers may provide complementary insights into early systemic inflammatory and hematologic responses in HIE. Prospective multicenter studies are needed to determine their prognostic value and relationship with clinical and neurodevelopmental outcomes.